Evaluation of serological assays for the diagnosis of childhood tuberculosis disease: a study protocol

Daniela Neudecker1, Nora Fritschi1,2, Thomas Sutter3

  • 1Mycobacterial and Migrant Health Research Group, Department of Clinical Research, University of Basel Children's Hospital Basel, University of Basel, Spitalstrasse 33, Basel, CH-4031, Switzerland.

PubMed

Insights

Developing a sensitive point-of-care test for childhood tuberculosis (TB) is crucial. This study evaluates serological assays to accurately diagnose TB disease in children, distinguishing it from other respiratory infections and TB infection.

Area of Science:

  • Pediatric infectious diseases
  • Immunology
  • Diagnostic assay development

Background:

  • Tuberculosis (TB) presents a significant global health burden, with a high number of undetected pediatric cases.
  • Accurate and accessible diagnostic tools for childhood TB are urgently needed, especially for point-of-care use.
  • Current diagnostic methods often fall short in sensitivity and accessibility for pediatric populations.

Purpose of the Study:

  • To evaluate the performance of serological assays in diagnosing TB disease in children aged 0-18 years.
  • To differentiate TB disease from healthy TB-exposed children, non-TB lower respiratory tract infections, and latent TB infection.
  • To identify key antigen targets and antibody features for improved diagnostic accuracy.

Main Methods:

  • Utilized biobanked plasma samples from three multicentric observational studies (CITRUS, pTBred, ProPAED).
  • Included children with confirmed TB disease, TB infection, healthy TB-exposed children, and those with non-TB lower respiratory tract infections.
  • Performed serological multiplex assays to analyze Mycobacterium tuberculosis antigen-specific antibodies, including isotypes, subclasses, Fc receptor binding, and IgG glycosylation.

Main Results:

  • Results are pending analysis; the study aims to identify specific serological markers for TB diagnosis in children.

Conclusions:

  • Findings will guide the design of novel serological assays for childhood TB diagnosis.
  • Developed assays have the potential for low-cost, point-of-care application, benefiting resource-limited settings.
  • This research could significantly improve the detection and management of TB in pediatric populations worldwide.
Abstract